Spondyloenchondrodysplasia Latest Advances
Find the Latest Research About Spondyloenchondrodysplasia
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 73 publications
Janus kinase inhibitor therapy for the treatment of spondyloenchondrodysplasia with immune dysregulation due to novel ACP5 variants: a multicenter study.
Journal: Frontiers in immunology
Published: January 15, 2026
Monogenic lupus secondary to spondyloenchondrodysplasia with immune dysregulation.
Journal: Joint bone spine
Published: December 18, 2025
Oral and Craniofacial Development and Immunology.
Journal: Advances in experimental medicine and biology
Published: November 12, 2025
Spondyloenchondrodysplasia: An enigmatic immuno-osseus type I interferonopathy.
Journal: Journal of human immunity
Published: October 06, 2025
Genetic Diseases Mimicking Rheumatic Disorders: Insights From Southeastern Turkey.
Journal: American journal of medical genetics. Part A
Published: April 18, 2025
Case Report: Successful treatment of spondyloenchondrodysplasia with immune dysregulation using tofacitinib and ruxolitinib: a report of two pediatric cases.
Journal: Frontiers in pharmacology
Published: March 24, 2025
Dual Targeted Therapy with Baricitinib and Anifrolumab in Infantile Spondyloenchondrodysplasia with Immune Dysregulation.
Journal: Journal of clinical immunology
Published: March 19, 2025
Spondyloenchondrodysplasia with immune dysregulation: an under-the-radar cause of spasticity.
Journal: Journal of Yeungnam medical science
Published: March 08, 2025
Clinical, laboratory, and molecular characteristics of patients with spondyloenchondrodysplasia: a case series study.
Journal: European journal of pediatrics
Published: October 07, 2024
Last Updated: 06/30/2026